CV/COS Webinar: Clip 16

During the insightful discussion, the potential use of real-world data for a synthetic control arm in clinical trials was explored. Carevive’s commitment to adhering to regulatory standards for electronic data capture sets a strong foundation for future opportunities in optimizing this data for regulatory interactions. While no definitive commitments can be made, the increasing patient numbers and rigorous methods prioritized by Carevive offer hope for real-world data to play a significant role in regulatory decision-making. Collaborating with Aaron and his team, Carevive aims to contribute to the advancement of oncology research and elevate patient outcomes through the integration of real-world evidence.

Recent Episodes

Cardiovascular care is entering one of its most transformative periods in decades. Advances in AI imaging and minimally invasive procedures are transforming the diagnosis and treatment of heart disease. According to the World Health Organization, an estimated 19.8 million people died from cardiovascular diseases in 2022, representing approximately 32% of all global deaths. This…

Across America, rural hospitals are facing an existential crisis. From physician burnout and recruitment struggles to malpractice insurance woes and shrinking OB units, the challenges facing small health systems are multiplying. According to the National Rural Health Association, roughly 190 rural hospitals have closed down or discontinued inpatient care since 2010 — and many more…

In this episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims, Chief Marketing Officer of TruMerit, welcomes Laura Messineo, Chief Nursing Officer at WorldWide HealthStaff Solutions. With more than 35 years of nursing experience and two decades pioneering virtual health, Laura shares her expertise in using telehealth to expand access, empower clinicians,…